ESR1 and breast carcinoma: Unlike other subtypes of breast cancer, triple‐negative breast cancer cells (TNBCs) lack the expression of hormonal receptors such as Estrogen receptor (ER), Progesterone receptor (PR), and Human epidermal growth factor receptor 2 (HER2) resulting in difficulty in targeting with hormonal receptor‐targeted therapeutics.